Tocqueville Asset Management’s Puma Biotechnology PBYI Stock Holding History
Bought
Maintained
Sold
Other funds holding PBYI
ACA
Tocqueville Asset Management's PBYI Position: Q3 2026 in Review
Tocqueville Asset Management held its Puma Biotechnology (PBYI) position steady in Q3 2026 at 13,312 shares worth $132K. The position accounts for ﹤0.01% of the portfolio, ranked #539.
Tocqueville Asset Management first reported a position in PBYI in Q4 2013 and has held it in 12 quarters since. The position peaked at $1.98M in Q3 2014. 156 funds tracked by Wall St. Rank hold PBYI as of Q3 2026.
- Tocqueville Asset Management held 13,312 shares of Puma Biotechnology worth $132K as of Q3 2026.
- Tocqueville Asset Management left its Puma Biotechnology share count unchanged in Q3 2026.
- Puma Biotechnology made up ﹤0.01% of Tocqueville Asset Management's portfolio in Q3 2026, its #539 holding.
- Tocqueville Asset Management first reported a position in Puma Biotechnology in Q4 2013 and has held it in 12 quarters since.
- Tocqueville Asset Management's Puma Biotechnology position peaked at $1.98M in Q3 2014.
- 156 funds tracked by Wall St. Rank held Puma Biotechnology as of Q3 2026.
Based on Tocqueville Asset Management's 13F filing for Q3 2026, filed 13 Nov 2026.